title: One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.
abstract: OBJECTIVE
  To describe the clinical features and complications of diabetic retinopathy, visual acuity, and number of repeat treatments after panretinal photocoagulation for proliferative diabetic retinopathy in a tertiary care center.
  
  
  METHODS
  A cohort study was conducted with data collection from medical records of patients undergoing panretinal photocoagulation between 1985 and 1995 at the Scheie Eye Institute; 297 eyes of 186 patients were eligible for study.
  
  
  RESULTS
  The presence of neovascularization of the disk at baseline, an earlier onset of diabetes, and a shorter duration of disease before panretinal photocoagulation were the strongest risk factors for needing an additional panretinal photocoagulation treatment. Sixty-two percent of eyes with poor visual acuity (< or =20/200) at baseline still had poor visual acuity at 1 year, and 76% with good visual acuity (> or =20/40) at baseline maintained good visual acuity at 1 year. Poor vision at baseline was the only risk factor for having poor vision at 1 year. Vitreous hemorrhage was present in 44% of eyes at baseline. New vitreous hemorrhage developed in 37% of eyes during the first year after panretinal photocoagulation. A traction retinal detachment was present in 4% of eyes at baseline and newly developed in 6% of eyes during follow-up. A repeat panretinal photocoagulation treatment was performed in 39% of eyes after initial treatment. A vitrectomy was performed in 10% of eyes from baseline through the 1-year follow-up visit.
  
  
  CONCLUSIONS
  The data from this study are useful for counseling patients with respect to likely visual outcome, possibility of major complications from proliferative diabetic retinopathy, and the chance of undergoing additional laser treatment after panretinal photocoagulation.
authors.affiliation: Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia 19104, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Kaiser
authors.forename: M G
authors.initials: MG
authors.lastname: Maguire
authors.forename: J E
authors.initials: JE
authors.lastname: Grunwald
authors.forename: D
authors.initials: D
authors.lastname: Lieb
authors.forename: B
authors.initials: B
authors.lastname: Jani
authors.forename: A J
authors.initials: AJ
authors.lastname: Brucker
authors.forename: A M
authors.initials: AM
authors.lastname: Maguire
authors.forename: A C
authors.initials: AC
authors.lastname: Ho
authors.forename: S L
authors.initials: SL
authors.lastname: Fine
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D003930:Diabetic Retinopathy / Q000601:surgery*; D005260:Female; D006801:Humans; D017075:Laser Coagulation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012086:Reoperation; D012160:Retina / Q000601:surgery*; D016896:Treatment Outcome; D014792:Visual Acuity; D014821:Vitrectomy